“We initially underestimated the complexity of integrating a small acquisition into our company. One could imagine that a smaller North American pharma company would easily roll into our US business. Looking back, we didn’t fully appreciate the differences in culture, size and business model between the two organizations. You helped us see that instead of doing X and disrupting their existing business model, we could do Y and work together to achieve the ultimate objective.
What began as an integration exercise with you effectively developed into a roadmap for our Management Team’s 2020 aspirations. We appreciate your approach, candid feedback and genuine interest in our success that transformed a challenging situation into an engaging and forward-looking collaboration.”
– VP, Strategic Affairs, specialty generic drug manufacturer